S D Rosenzweig

Summary

Country: Argentina

Publications

  1. ncbi Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome
    S D Rosenzweig
    Servicio de Inmunologia, Hospital Nacional de Pediatria J P Garrahan, Buenos Aires, Argentina
    J Infect 52:e69-72. 2006
  2. ncbi Inflammatory manifestations in chronic granulomatous disease (CGD)
    S D Rosenzweig
    Servicio de Inmunologia, Hospital Nacional de Pediatria J P Garrahan, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina
    J Clin Immunol 28:S67-72. 2008
  3. ncbi Chronic granulomatous disease: complications and management
    Sergio D Rosenzweig
    , , Combate de los Pozos 1881 1245, Buenos Aires, Argentina
    Expert Rev Clin Immunol 5:45-53. 2009
  4. ncbi A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants
    J Yancoski
    Hospital Nacional de Pediatria JP Garrahan, Buenos Aires, Argentina
    Infect Genet Evol 9:574-80. 2009
  5. ncbi Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease
    P E Santos
    , , Buenos Aires, Argentina
    Med Mycol 44:749-53. 2006
  6. ncbi Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood
    M L Galluzzo
    Servicio de Patologia, Hospital Nacional de Pediatria J P Garrahan, Buenos Aires, Argentina
    Clin Infect Dis 46:745-9. 2008

Collaborators

  • S M Holland
  • M L Galluzzo
  • J Yancoski
  • M Oleastro
  • P E Santos
  • F Haerynck
  • A Bernasconi
  • C Rocco
  • L Bezrodnik
  • C Vrátnica
  • L Perez
  • M Zelazko
  • C Hernandez
  • M T G Davila
  • E Piontelli
  • Y R Shea
  • M E Zelazko

Detail Information

Publications6

  1. ncbi Thirteen years of culture-positive M. bovis-BCG infection in an IL-12Rbeta1 deficient patient: treatment and outcome
    S D Rosenzweig
    Servicio de Inmunologia, Hospital Nacional de Pediatria J P Garrahan, Buenos Aires, Argentina
    J Infect 52:e69-72. 2006
    ..A combined parenteral and enteral anti-mycobacterial treatment, including recombinant IFNgamma, helped to clear his infection...
  2. ncbi Inflammatory manifestations in chronic granulomatous disease (CGD)
    S D Rosenzweig
    Servicio de Inmunologia, Hospital Nacional de Pediatria J P Garrahan, Combate de los Pozos 1881, 1245 Buenos Aires, Argentina
    J Clin Immunol 28:S67-72. 2008
    ..In this review we will focus our attention on those particular inflammatory manifestations associated with CGD, their frequencies and the underlying immunologic mechanisms favoring it occurrence...
  3. ncbi Chronic granulomatous disease: complications and management
    Sergio D Rosenzweig
    , , Combate de los Pozos 1881 1245, Buenos Aires, Argentina
    Expert Rev Clin Immunol 5:45-53. 2009
    ..Very encouraging and promising results have been recently achieved, with definitive and curative options for this disease now available...
  4. ncbi A 475 years-old founder effect involving IL12RB1: a highly prevalent mutation conferring Mendelian Susceptibility to Mycobacterial Diseases in European descendants
    J Yancoski
    Hospital Nacional de Pediatria JP Garrahan, Buenos Aires, Argentina
    Infect Genet Evol 9:574-80. 2009
    ..The reason(s) behind the persistency of this mutation across multiple generations, its relative high prevalence, and any potential selective advantage are yet to be established...
  5. ncbi Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease
    P E Santos
    , , Buenos Aires, Argentina
    Med Mycol 44:749-53. 2006
    ..Microbiological, microscopic and molecular studies support the fungal diagnosis. P. piceum should be considered as a relevant pathogen in immunocompromised patients...
  6. ncbi Clinical and histopathological features and a unique spectrum of organisms significantly associated with chronic granulomatous disease osteomyelitis during childhood
    M L Galluzzo
    Servicio de Patologia, Hospital Nacional de Pediatria J P Garrahan, Buenos Aires, Argentina
    Clin Infect Dis 46:745-9. 2008
    ..In patients with these findings, anti-infective prophylactic measures aiming to cover highly prevalent microorganisms, as well as aggressive therapeutic measures, should be strongly encouraged...